Media

Follow the latest news coverage of Think Research. For financial information, visit our Investor Relations hub.

Featured in

torontostar300
globeandmail300
fp300
cbc300
bnn300
global300

A casual observer might look at Think Research Corp.’s products and peg the Toronto-based company as a maker of digital checklists, forms and telemedicine apps.

That much is true – but it’s only part of the company’s story.

“We make software for health-care providers that organizes medical knowledge and data to improve patient care and support better decisions,” explains Sachin Aggarwal, chief executive officer of Think Research, which was founded in 2006 by an Ontario critical care physician who saw the inherent inefficiencies – and potential for error – in handwritten treatment orders.

Read the Globe and Mail piece featuring Think CEO Sachin Aggarwal here.

Think CEO Sachin Aggarwal spoke to BNN host Amanda Lang about the company’s work combating vaccine hesitancy and how we’re helping healthcare providers deliver care during the pandemic.

Lowering the age group for COVID-19 vaccines means more shots in the arms of Canadians. That’s a good thing, especially as case counts soar and already stretched-thin hospitals struggle to keep up with a surge of patients.

But while COVID-19 vaccines are shown to be effective and safe, changing guidance and poor communication has shadowed the vaccine rollout. That has led to confusion, vaccine shopping, and in some cases, flat-out refusal to get the jab. As more Canadians are able to get the vaccine, the overarching message should be that the best vaccine is the one you are offered.

Read the Hamilton Spectator opinion piece by Think pharmacists Amarpreet Singh and Nihal Abbas here.

“Is there really a material difference between two telemedicine platforms if they’re just providing that simple [doctor’s] visit? Probably not,” says Sachin Aggarwal, CEO of Toronto-based digital health company Think Research.

“What’s going to differentiate these companies in the future is going to be if they’re able to provide some of the more complex workflows that the health care system is going to demand.”

Read the Globe and Mail article featuring Think CEO Sachin Aggarwal here.

Overcoming vaccine hesitancy may be as simple as making a phone call, according to a new study that highlights the vital role pharmacists play in getting some people to roll up their sleeves.

The program, developed by MDBriefCase and published in the journal Vaccines, discovered that a brief conversation with a pharmacist was enough to convince 67 per cent of vaccine-hesitant patients 65 years of age and older to get the flu shot. It also uncovered that there is more than just skepticism hiking the rate of hesitancy.

Read the Healthing article featuring MDBriefCase’s findings here.

Think Research Corporation launched an educational hub to help clinicians and family physicians promote vaccine confidence and reduce vaccine hesitancy, which is a growing area of concern, says CEO Sachin Aggarwal.

“Docs are a real key part of this story,” he said. “Evidence has changed so fast over the course of COVID. Doctors are like you and me, they keep on top of it the best they can, but things are changing rapidly so you need to arm them, and they need to know how to most effectively communicate that information with their patients.”

Read the Medicine Hat News article featuring Think’s CEO Sachin Aggarwal here.

Ontario’s finance minister says he will eliminate the fax machine in government — a long overdue step to drag the public service into the 21st century. He should be applauded for pulling the plug, as our reliance on the cumbersome devices is both antiquated and costly. Now, it’s time to take the next logical step and extend that order to health-care systems across the province and across Canada.

Read the Toronto Star opinion piece by managing director of clinical services Dr. Parminder Singh and CEO Sachin Aggarwal here.

BNN Bloomberg analyst Stephen Takacsy highlighted Think Research as a top pick during BNN’s markets segment on March 22. Find out more here.

TMX

Watch Think CEO Sachin Aggarwal talk about the company’s growth on the TMX series here.

Vaccine hesitancy is a legitimate concern – one that’s being amplified by the COVID-19 pandemic. We know that government officials are worried about it, and Ottawa has set up a team of behavioural scientists to monitor how Canadians feel about vaccines and public-health messaging.

Read the opinion piece in the Globe and Mail written by Think CEO Sachin Aggarwal, Managing Director Jason Flowerday, and Managing Director of Clinical Services Dr. Parminder Singh here.

The overdose order set, developed by Think Research and customized for each hospital, streamlines the process of treating patients for clinicians and looks at planning a person’s discharge from the hospital, as well as connecting them to other community supports, such as rapid access addiction medicine (RAAM) clinics.

Find out more here.

A Toronto medical clinic is reopening after being closed for several months because of the pandemic. The Imagine Clinic serves some of the city’s most vulnerable people. As of Saturday, the facility will be offering virtual appointments with the support of Think Research.

Find out more here.

Standardizing the world’s health knowledge so that everyone can get the best care possible seems like a lofty mission for one company, but if any Canadian health-tech startup can make it happen, Think Research Corp. may be the safest bet.

Find out more here.

Health-tech scale-up Think Research Corp. is buying fellow Toronto company MDBriefCase Group Inc. for $25.3-million in shares and cash, adding to its suite of tools that keep medical professionals up to date with evidence-based research.

Find out more here.

Toronto-based health-tech company Think Research is starting the New Year with big goals, and executive vice-president Mark Sakamoto is excited for the company’s future.

Find out more here.

Mark Sakamoto and business partner Sachin Aggarwal’s digital health company Think Research has made another big move in the business world.

Find out more here.

Following its recent debut on the Toronto Stock Exchange (TSX), Think Research, a developer of virtual care technology and clinical treatment protocols, is set to acquire Clinic 360, a cosmetic and elective surgery clinic based in Toronto.

Find out more here.

Toronto health-tech company Think Research Corp. became the latest Canadian scale-up to list on public markets Wednesday, as it tries to take advantage of investors’ growing appetite for virtual care with a blend of digital and physical offerings.

Find out more here.

Media inquiries

Journalists can contact Think Research with questions or to arrange an interview by emailing communications@thinkresearch.com.

Stay up to date

Join our investor news mailing list. You can unsubscribe at any time.